Seeger Weiss Represents Arlington County, Virginia in Insulin Pricing Lawsuit

Seeger Weiss attorneys Chris Seeger, David Buchanan and Steven Daroci filed a lawsuit on behalf of Arlington County, Virginia against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi, and pharmacy benefit managers (PBMs) CVS Caremark, Express Scripts and OptumRx, for their alleged role in a scheme to aggressively inflate the price of insulin and other […]

November 14, 2023

Seeger Weiss attorneys Chris Seeger, David Buchanan and Steven Daroci filed a lawsuit on behalf of Arlington County, Virginia against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi, and pharmacy benefit managers (PBMs) CVS Caremark, Express Scripts and OptumRx, for their alleged role in a scheme to aggressively inflate the price of insulin and other diabetes medications.

Over the past 20 years, the cost of insulin has risen several hundred percent, far outpacing the increase in the cost of production. This price inflation has not only placed a heavy financial burden on individuals who require insulin to manage their diabetes but also on government entities like Arlington County that bear the brunt of these inflated prices. The lawsuit seeks to recover damages for the increased costs borne by Arlington County due to the alleged pricing scheme and to prevent these companies from continuing their alleged unlawful, deceptive, and anticompetitive practices.

This case reflects Seeger Weiss’ ongoing commitment to representing clients in important public health litigation. The firm currently represents several government entities, including Albany County, New York; Lake County, Illinois; Monmouth County, New Jersey; the City of Cleveland, Ohio; and others that have filed similar lawsuits alleging that insulin manufacturers and PBMs are complicit in overcharging for these life-saving diabetes medications. Additionally, Seeger Weiss and its co-counsel successfully argued for the creation of a multidistrict litigation for these insulin pricing lawsuits in the District of New Jersey. The Judicial Panel on Multidistrict Litigation created the In re: Insulin Pricing Litigation MDL in August of this year.

One of the nation’s preeminent plaintiffs’ law firms, Seeger Weiss is best known for multidistrict mass torts and class actions in both state and federal court—and especially for taking those cases to trial. With the resources and dedication to take on the world’s largest corporations, the firm has an impressive track record of victories against companies like Merck, Monsanto, and 3M—and a reputation for sticking with a case from beginning to end. From offices in New York, New Jersey, Pennsylvania, and Massachusetts, the firm has represented over 10,000 individuals, companies, and governments across the United States who have been injured or defrauded on a massive scale. Since its founding in 1999, it has led many of the most complex and high-profile cases in the country: the National Prescription Opiate Litigation, which the Washington Post called “the largest federal court case in U.S. history”; the ongoing “Dieselgate” scandal; the sprawling multistate litigation on behalf of survivors of child sexual abuse; and the history-making National Football League Players’ Concussion Injury Litigation.

Related News

May 9, 2024
Seeger Weiss Reaches $1.1 Billion Personal Injury and Medical Monitoring Settlement in Philips CPAPs, Bi-PAPs, and Ventilators Litigation

Seeger Weiss founder and court-appointed co-lead counsel Chris Seeger secured a nearly $1.1 billion settlement in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation. The agreement provides $1.075 billion to compensate patients who suffered injuries while using recalled Philips devices and also includes $25 million to cover the cost of medical monitoring […]

Read More
May 9, 2024
Seeger Weiss Partner Parvin Aminolroaya Appointed Co-lead Counsel In Ozempic Litigation

RIDGEFIELD PARK, NJ — Seeger Weiss is pleased to announce that partner Parvin K. Aminolroaya has been appointed to serve as plaintiffs’ co-lead counsel in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation by the honorable Judge Gene E. K. Pratter. This litigation consolidates dozens of lawsuits against drugmakers Novo Nordisk and Eli […]

Read More
April 26, 2024
Seeger Weiss Secures Final Approval of Philips CPAP Economic Loss Class Action Settlement

On April 25, 2024, Judge Joy Flowers Conti of the Western District of Pennsylvania granted final approval to the economic loss class action settlement negotiated by Seeger Weiss partner Chris Seeger and his fellow co-lead plaintiffs’ counsel in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation. The uncapped settlement provides more than […]

Read More